Table of Content

1 Hormonal Contraception Market Overview
1.1 Product Overview and Scope of Hormonal Contraception
1.2 Hormonal Contraception Segment by Hormone
1.2.1 Global Hormonal Contraception Market Value Comparison by Hormone (2024-2034)
1.2.2 Androgens
1.2.3 Estrogens
1.2.4 Progestrogens
1.2.5 Antiandrogens
1.2.6 Gonadotropins
1.3 Hormonal Contraception Segment by Application
1.3.1 Global Hormonal Contraception Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Gynaecology Centers
1.3.5 Others
1.4 Global Hormonal Contraception Market Size Estimates and Forecasts
1.4.1 Global Hormonal Contraception Revenue 2018-2034
1.4.2 Global Hormonal Contraception Sales 2018-2034
1.4.3 Global Hormonal Contraception Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Hormonal Contraception Market Competition by Manufacturers
2.1 Global Hormonal Contraception Sales Market Share by Manufacturers (2018-2023)
2.2 Global Hormonal Contraception Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Hormonal Contraception Average Price by Manufacturers (2018-2023)
2.4 Global Hormonal Contraception Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Hormonal Contraception, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hormonal Contraception, Product Type & Application
2.7 Hormonal Contraception Market Competitive Situation and Trends
2.7.1 Hormonal Contraception Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hormonal Contraception Players Market Share by Revenue
2.7.3 Global Hormonal Contraception Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hormonal Contraception Retrospective Market Scenario by Region
3.1 Global Hormonal Contraception Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Hormonal Contraception Global Hormonal Contraception Sales by Region: 2018-2034
3.2.1 Global Hormonal Contraception Sales by Region: 2018-2023
3.2.2 Global Hormonal Contraception Sales by Region: 2024-2034
3.3 Global Hormonal Contraception Global Hormonal Contraception Revenue by Region: 2018-2034
3.3.1 Global Hormonal Contraception Revenue by Region: 2018-2023
3.3.2 Global Hormonal Contraception Revenue by Region: 2024-2034
3.4 North America Hormonal Contraception Market Facts & Figures by Country
3.4.1 North America Hormonal Contraception Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Hormonal Contraception Sales by Country (2018-2034)
3.4.3 North America Hormonal Contraception Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hormonal Contraception Market Facts & Figures by Country
3.5.1 Europe Hormonal Contraception Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Hormonal Contraception Sales by Country (2018-2034)
3.5.3 Europe Hormonal Contraception Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hormonal Contraception Market Facts & Figures by Country
3.6.1 Asia Pacific Hormonal Contraception Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Hormonal Contraception Sales by Country (2018-2034)
3.6.3 Asia Pacific Hormonal Contraception Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hormonal Contraception Market Facts & Figures by Country
3.7.1 Latin America Hormonal Contraception Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Hormonal Contraception Sales by Country (2018-2034)
3.7.3 Latin America Hormonal Contraception Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hormonal Contraception Market Facts & Figures by Country
3.8.1 Middle East and Africa Hormonal Contraception Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Hormonal Contraception Sales by Country (2018-2034)
3.8.3 Middle East and Africa Hormonal Contraception Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hormonal Contraception Sales by Type (2018-2034)
4.1.1 Global Hormonal Contraception Sales by Type (2018-2023)
4.1.2 Global Hormonal Contraception Sales by Type (2024-2034)
4.1.3 Global Hormonal Contraception Sales Market Share by Type (2018-2034)
4.2 Global Hormonal Contraception Revenue by Type (2018-2034)
4.2.1 Global Hormonal Contraception Revenue by Type (2018-2023)
4.2.2 Global Hormonal Contraception Revenue by Type (2024-2034)
4.2.3 Global Hormonal Contraception Revenue Market Share by Type (2018-2034)
4.3 Global Hormonal Contraception Price by Type (2018-2034)
5 Segment by Application
5.1 Global Hormonal Contraception Sales by Application (2018-2034)
5.1.1 Global Hormonal Contraception Sales by Application (2018-2023)
5.1.2 Global Hormonal Contraception Sales by Application (2024-2034)
5.1.3 Global Hormonal Contraception Sales Market Share by Application (2018-2034)
5.2 Global Hormonal Contraception Revenue by Application (2018-2034)
5.2.1 Global Hormonal Contraception Revenue by Application (2018-2023)
5.2.2 Global Hormonal Contraception Revenue by Application (2024-2034)
5.2.3 Global Hormonal Contraception Revenue Market Share by Application (2018-2034)
5.3 Global Hormonal Contraception Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Bayer AG
6.1.1 Bayer AG Corporation Information
6.1.2 Bayer AG Description and Business Overview
6.1.3 Bayer AG Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Bayer AG Hormonal Contraception Product Portfolio
6.1.5 Bayer AG Recent Developments/Updates
6.2 Merck & Co., Inc.
6.2.1 Merck & Co., Inc. Corporation Information
6.2.2 Merck & Co., Inc. Description and Business Overview
6.2.3 Merck & Co., Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck & Co., Inc. Hormonal Contraception Product Portfolio
6.2.5 Merck & Co., Inc. Recent Developments/Updates
6.3 Pfizer, Inc.
6.3.1 Pfizer, Inc. Corporation Information
6.3.2 Pfizer, Inc. Description and Business Overview
6.3.3 Pfizer, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer, Inc. Hormonal Contraception Product Portfolio
6.3.5 Pfizer, Inc. Recent Developments/Updates
6.4 Agile Therapeutics, Inc.
6.4.1 Agile Therapeutics, Inc. Corporation Information
6.4.2 Agile Therapeutics, Inc. Description and Business Overview
6.4.3 Agile Therapeutics, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Agile Therapeutics, Inc. Hormonal Contraception Product Portfolio
6.4.5 Agile Therapeutics, Inc. Recent Developments/Updates
6.5 Teva Pharmaceutical Industries Ltd.
6.5.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.5.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.5.3 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Teva Pharmaceutical Industries Ltd. Hormonal Contraception Product Portfolio
6.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.6 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Amgen Hormonal Contraception Product Portfolio
6.6.5 Amgen Recent Developments/Updates
6.7 Cipla Ltd.
6.6.1 Cipla Ltd. Corporation Information
6.6.2 Cipla Ltd. Description and Business Overview
6.6.3 Cipla Ltd. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cipla Ltd. Hormonal Contraception Product Portfolio
6.7.5 Cipla Ltd. Recent Developments/Updates
6.8 Glenmark Pharmaceuticals Inc.
6.8.1 Glenmark Pharmaceuticals Inc. Corporation Information
6.8.2 Glenmark Pharmaceuticals Inc. Description and Business Overview
6.8.3 Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Glenmark Pharmaceuticals Inc. Hormonal Contraception Product Portfolio
6.8.5 Glenmark Pharmaceuticals Inc. Recent Developments/Updates
6.9 Lupin Limited(Lupin Pharmaceuticals, Inc.)
6.9.1 Lupin Limited(Lupin Pharmaceuticals, Inc.) Corporation Information
6.9.2 Lupin Limited(Lupin Pharmaceuticals, Inc.) Description and Business Overview
6.9.3 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Product Portfolio
6.9.5 Lupin Limited(Lupin Pharmaceuticals, Inc.) Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Corporation Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Novartis AG Hormonal Contraception Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
6.11 Mylan N.V.
6.11.1 Mylan N.V. Corporation Information
6.11.2 Mylan N.V. Hormonal Contraception Description and Business Overview
6.11.3 Mylan N.V. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Mylan N.V. Hormonal Contraception Product Portfolio
6.11.5 Mylan N.V. Recent Developments/Updates
6.12 Johnson & Johnson
6.12.1 Johnson & Johnson Corporation Information
6.12.2 Johnson & Johnson Hormonal Contraception Description and Business Overview
6.12.3 Johnson & Johnson Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Johnson & Johnson Hormonal Contraception Product Portfolio
6.12.5 Johnson & Johnson Recent Developments/Updates
6.13 Ansell LTD
6.13.1 Ansell LTD Corporation Information
6.13.2 Ansell LTD Hormonal Contraception Description and Business Overview
6.13.3 Ansell LTD Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Ansell LTD Hormonal Contraception Product Portfolio
6.13.5 Ansell LTD Recent Developments/Updates
6.14 Mayer Laboratories, Inc.
6.14.1 Mayer Laboratories, Inc. Corporation Information
6.14.2 Mayer Laboratories, Inc. Hormonal Contraception Description and Business Overview
6.14.3 Mayer Laboratories, Inc. Hormonal Contraception Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Mayer Laboratories, Inc. Hormonal Contraception Product Portfolio
6.14.5 Mayer Laboratories, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hormonal Contraception Industry Chain Analysis
7.2 Hormonal Contraception Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hormonal Contraception Production Mode & Process
7.4 Hormonal Contraception Sales and Marketing
7.4.1 Hormonal Contraception Sales Channels
7.4.2 Hormonal Contraception Distributors
7.5 Hormonal Contraception Customers
8 Hormonal Contraception Market Dynamics
8.1 Hormonal Contraception Industry Trends
8.2 Hormonal Contraception Market Drivers
8.3 Hormonal Contraception Market Challenges
8.4 Hormonal Contraception Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Hormonal Contraception Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Hormonal Contraception Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Hormonal Contraception Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hormonal Contraception Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Hormonal Contraception Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Hormonal Contraception Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Hormonal Contraception Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Hormonal Contraception Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Hormonal Contraception, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Hormonal Contraception, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hormonal Contraception, Product Type & Application
Table 12. Global Key Manufacturers of Hormonal Contraception, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hormonal Contraception by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormonal Contraception as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hormonal Contraception Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Hormonal Contraception Sales by Region (2018-2023) & (K Units)
Table 18. Global Hormonal Contraception Sales Market Share by Region (2018-2023)
Table 19. Global Hormonal Contraception Sales by Region (2024-2034) & (K Units)
Table 20. Global Hormonal Contraception Sales Market Share by Region (2024-2034)
Table 21. Global Hormonal Contraception Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Hormonal Contraception Revenue Market Share by Region (2018-2023)
Table 23. Global Hormonal Contraception Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Hormonal Contraception Revenue Market Share by Region (2024-2034)
Table 25. North America Hormonal Contraception Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Hormonal Contraception Sales by Country (2018-2023) & (K Units)
Table 27. North America Hormonal Contraception Sales by Country (2024-2034) & (K Units)
Table 28. North America Hormonal Contraception Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Hormonal Contraception Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Hormonal Contraception Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Hormonal Contraception Sales by Country (2018-2023) & (K Units)
Table 32. Europe Hormonal Contraception Sales by Country (2024-2034) & (K Units)
Table 33. Europe Hormonal Contraception Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Hormonal Contraception Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Hormonal Contraception Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Hormonal Contraception Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Hormonal Contraception Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Hormonal Contraception Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Hormonal Contraception Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Hormonal Contraception Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Hormonal Contraception Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Hormonal Contraception Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Hormonal Contraception Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Hormonal Contraception Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Hormonal Contraception Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Hormonal Contraception Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Hormonal Contraception Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Hormonal Contraception Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Hormonal Contraception Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Hormonal Contraception Sales (K Units) by Type (2018-2023)
Table 51. Global Hormonal Contraception Sales (K Units) by Type (2024-2034)
Table 52. Global Hormonal Contraception Sales Market Share by Type (2018-2023)
Table 53. Global Hormonal Contraception Sales Market Share by Type (2024-2034)
Table 54. Global Hormonal Contraception Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Hormonal Contraception Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Hormonal Contraception Revenue Market Share by Type (2018-2023)
Table 57. Global Hormonal Contraception Revenue Market Share by Type (2024-2034)
Table 58. Global Hormonal Contraception Price (US$/Unit) by Type (2018-2023)
Table 59. Global Hormonal Contraception Price (US$/Unit) by Type (2024-2034)
Table 60. Global Hormonal Contraception Sales (K Units) by Application (2018-2023)
Table 61. Global Hormonal Contraception Sales (K Units) by Application (2024-2034)
Table 62. Global Hormonal Contraception Sales Market Share by Application (2018-2023)
Table 63. Global Hormonal Contraception Sales Market Share by Application (2024-2034)
Table 64. Global Hormonal Contraception Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Hormonal Contraception Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Hormonal Contraception Revenue Market Share by Application (2018-2023)
Table 67. Global Hormonal Contraception Revenue Market Share by Application (2024-2034)
Table 68. Global Hormonal Contraception Price (US$/Unit) by Application (2018-2023)
Table 69. Global Hormonal Contraception Price (US$/Unit) by Application (2024-2034)
Table 70. Bayer AG Corporation Information
Table 71. Bayer AG Description and Business Overview
Table 72. Bayer AG Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Bayer AG Hormonal Contraception Product
Table 74. Bayer AG Recent Developments/Updates
Table 75. Merck & Co., Inc. Corporation Information
Table 76. Merck & Co., Inc. Description and Business Overview
Table 77. Merck & Co., Inc. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Merck & Co., Inc. Hormonal Contraception Product
Table 79. Merck & Co., Inc. Recent Developments/Updates
Table 80. Pfizer, Inc. Corporation Information
Table 81. Pfizer, Inc. Description and Business Overview
Table 82. Pfizer, Inc. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Pfizer, Inc. Hormonal Contraception Product
Table 84. Pfizer, Inc. Recent Developments/Updates
Table 85. Agile Therapeutics, Inc. Corporation Information
Table 86. Agile Therapeutics, Inc. Description and Business Overview
Table 87. Agile Therapeutics, Inc. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Agile Therapeutics, Inc. Hormonal Contraception Product
Table 89. Agile Therapeutics, Inc. Recent Developments/Updates
Table 90. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 91. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 92. Teva Pharmaceutical Industries Ltd. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Teva Pharmaceutical Industries Ltd. Hormonal Contraception Product
Table 94. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 95. Amgen Corporation Information
Table 96. Amgen Description and Business Overview
Table 97. Amgen Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Amgen Hormonal Contraception Product
Table 99. Amgen Recent Developments/Updates
Table 100. Cipla Ltd. Corporation Information
Table 101. Cipla Ltd. Description and Business Overview
Table 102. Cipla Ltd. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Cipla Ltd. Hormonal Contraception Product
Table 104. Cipla Ltd. Recent Developments/Updates
Table 105. Glenmark Pharmaceuticals Inc. Corporation Information
Table 106. Glenmark Pharmaceuticals Inc. Description and Business Overview
Table 107. Glenmark Pharmaceuticals Inc. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Glenmark Pharmaceuticals Inc. Hormonal Contraception Product
Table 109. Glenmark Pharmaceuticals Inc. Recent Developments/Updates
Table 110. Lupin Limited(Lupin Pharmaceuticals, Inc.) Corporation Information
Table 111. Lupin Limited(Lupin Pharmaceuticals, Inc.) Description and Business Overview
Table 112. Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Lupin Limited(Lupin Pharmaceuticals, Inc.) Hormonal Contraception Product
Table 114. Lupin Limited(Lupin Pharmaceuticals, Inc.) Recent Developments/Updates
Table 115. Novartis AG Corporation Information
Table 116. Novartis AG Description and Business Overview
Table 117. Novartis AG Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Novartis AG Hormonal Contraception Product
Table 119. Novartis AG Recent Developments/Updates
Table 120. Mylan N.V. Corporation Information
Table 121. Mylan N.V. Description and Business Overview
Table 122. Mylan N.V. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Mylan N.V. Hormonal Contraception Product
Table 124. Mylan N.V. Recent Developments/Updates
Table 125. Johnson & Johnson Corporation Information
Table 126. Johnson & Johnson Description and Business Overview
Table 127. Johnson & Johnson Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Johnson & Johnson Hormonal Contraception Product
Table 129. Johnson & Johnson Recent Developments/Updates
Table 130. Ansell LTD Corporation Information
Table 131. Ansell LTD Description and Business Overview
Table 132. Ansell LTD Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Ansell LTD Hormonal Contraception Product
Table 134. Ansell LTD Recent Developments/Updates
Table 135. Mayer Laboratories, Inc. Corporation Information
Table 136. Mayer Laboratories, Inc. Description and Business Overview
Table 137. Mayer Laboratories, Inc. Hormonal Contraception Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Mayer Laboratories, Inc. Hormonal Contraception Product
Table 139. Mayer Laboratories, Inc. Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Hormonal Contraception Distributors List
Table 143. Hormonal Contraception Customers List
Table 144. Hormonal Contraception Market Trends
Table 145. Hormonal Contraception Market Drivers
Table 146. Hormonal Contraception Market Challenges
Table 147. Hormonal Contraception Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hormonal Contraception
Figure 2. Global Hormonal Contraception Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Hormonal Contraception Market Share by Type in 2024 & 2034
Figure 4. Androgens Product Picture
Figure 5. Estrogens Product Picture
Figure 6. Progestrogens Product Picture
Figure 7. Antiandrogens Product Picture
Figure 8. Gonadotropins Product Picture
Figure 9. Global Hormonal Contraception Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Hormonal Contraception Market Share by Application in 2024 & 2034
Figure 11. Hospital
Figure 12. Clinics
Figure 13. Gynaecology Centers
Figure 14. Others
Figure 15. Global Hormonal Contraception Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Hormonal Contraception Market Size (2018-2034) & (US$ Million)
Figure 17. Global Hormonal Contraception Sales (2018-2034) & (K Units)
Figure 18. Global Hormonal Contraception Average Price (US$/Unit) & (2018-2034)
Figure 19. Hormonal Contraception Report Years Considered
Figure 20. Hormonal Contraception Sales Share by Manufacturers in 2024
Figure 21. Global Hormonal Contraception Revenue Share by Manufacturers in 2024
Figure 22. The Global 5 and 10 Largest Hormonal Contraception Players: Market Share by Revenue in 2024
Figure 23. Hormonal Contraception Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 24. Global Hormonal Contraception Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 25. North America Hormonal Contraception Sales Market Share by Country (2018-2034)
Figure 26. North America Hormonal Contraception Revenue Market Share by Country (2018-2034)
Figure 27. United States Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Canada Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Europe Hormonal Contraception Sales Market Share by Country (2018-2034)
Figure 30. Europe Hormonal Contraception Revenue Market Share by Country (2018-2034)
Figure 31. Germany Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. France Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. U.K. Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Italy Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Russia Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Asia Pacific Hormonal Contraception Sales Market Share by Region (2018-2034)
Figure 37. Asia Pacific Hormonal Contraception Revenue Market Share by Region (2018-2034)
Figure 38. China Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Japan Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. South Korea Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. India Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Australia Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. China Taiwan Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Indonesia Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Thailand Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Malaysia Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Latin America Hormonal Contraception Sales Market Share by Country (2018-2034)
Figure 48. Latin America Hormonal Contraception Revenue Market Share by Country (2018-2034)
Figure 49. Mexico Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Argentina Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Middle East & Africa Hormonal Contraception Sales Market Share by Country (2018-2034)
Figure 53. Middle East & Africa Hormonal Contraception Revenue Market Share by Country (2018-2034)
Figure 54. Turkey Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. UAE Hormonal Contraception Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Global Sales Market Share of Hormonal Contraception by Type (2018-2034)
Figure 58. Global Revenue Market Share of Hormonal Contraception by Type (2018-2034)
Figure 59. Global Hormonal Contraception Price (US$/Unit) by Type (2018-2034)
Figure 60. Global Sales Market Share of Hormonal Contraception by Application (2018-2034)
Figure 61. Global Revenue Market Share of Hormonal Contraception by Application (2018-2034)
Figure 62. Global Hormonal Contraception Price (US$/Unit) by Application (2018-2034)
Figure 63. Hormonal Contraception Value Chain
Figure 64. Hormonal Contraception Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed